稳心颗粒治疗慢性肺心病合并频发室性期前收缩

目的: 探讨稳心颗粒治疗慢性肺心病合并频发室性期前收缩的临床疗效和安全性。 方法: 于2010年11月-2012年11月按照随机数字表法将收治的慢性肺心病合并频发室性期前收缩患者随机分为研究组和对照组,其中研究组采用稳心颗粒治疗,并与采用常规综合治疗的对照组进行临床疗效和不良反应的对比研究。 结果: 研究组临床疗效和心电图疗效均明显优于对照组(P<0.05)。研究组患者治疗后对血液流变学改善情况明显优于对照组(P<0.05)。治疗后,研究组室性期前收缩次数明显低于对照组(P<0.05)。 结论: 稳心颗粒治疗慢性肺心病合并频发室性期前收缩的疗效确切,不良反应少,易于接受。

Clinical Study of Wenxin Granule in Treating Chronic Pulmonary Heart Disease Complicated by Ventricular Contractions

Objective: To investigate the clinical effect of Wenxin granule in treating chronic pulmonary heart disease complicated by ventricular contractions. Method: This study in 2010-11-2012-11 November in accordance with the random number table method treated the chronic pulmonary heart disease complicated with recurrent patients were randomly divided into study group and control group of premature ventricular contraction, the research group was treated with Wenxin granule, and carries out a comparative research on the clinical efficacy and adverse reactions and the control group with routine comprehensive therapy the. Result: The study group was significantly better than the control group in the clinical curative effect and electrocard iograph(ECG) efficacy (P<0.05). Patients in the study group after treatment on hemorheology significantly higher than those in control group (P<0.05). After treatment, the study group ventricular extrasystoles times lower than that of control group (P<0.05). Conclusion: Wenxin granule in the treatment of chronic pulmonary heart disease complicated by ventricular contractions had curative effect, less adverse reaction, and easy to accept.